Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00798382 · ClinicalTrials.gov registry record · Phase 2
Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Term Infants
A Phase 2 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 2
- Development phase
- 154
- Enrollment target
NCT00798382 is a Phase 2 study that has completed, run by Abbott Nutrition. The registered enrollment target is 154 participants.
The verdict
NCT00798382, a Phase 2 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 154 participants
- Enrollment target
Study Summary
The objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental soy-based formulas, relative to a commercially available soy-based formula.
Interventions
- OTHER soy protein formula
- OTHER Commercially available soy formula
- OTHER Soy formula experimental #2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00798382
The ClinicalTrials.gov registry entry for NCT00798382 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which soy protein formula is the first listed.
NCT00798382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00798382 about?
NCT00798382 is a clinical study titled "Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Term Infants". The objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental soy-based formulas, relative to a commercially available soy-based formula.
What is the current status of trial NCT00798382?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 154 participants. The study started on 2008-12. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00798382?
The interventions under investigation include: soy protein formula (OTHER), Commercially available soy formula (OTHER), Soy formula experimental #2 (OTHER).
Who is sponsoring clinical trial NCT00798382?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.